about
Relationship of the Content of Systemic and Endobronchial Soluble Molecules of CD25, CD38, CD8, and HLA-I-CD8 and Lung Function Parameters in COPD Patients.Characterization of a panel of monoclonal antibodies and mapping the epitopes of hepatitis C virus proteins.Characterization of monoclonal antibodies and epitope mapping of the NS4 protein of hepatitis C virus.Treatment by serum up-conversion nanoparticles in the fluoride matrix changes the mechanism of cell death and the elasticity of the membrane.Associations between indicators of nitrosative stress and levels of soluble HLA-I, CD95 molecules in patients with COPD.Nebulized budesonide in the treatment of exacerbations of chronic obstructive pulmonary disease: Efficacy, safety, and effects on the serum levels of soluble differentiation moleculesSoluble HLA-I and HLA-II Molecules Are Potential Prognostic Markers of Progression of Systemic and Local Inflammation in Patients with COPDPeripheral blood lymphocytes immunophenotype and serum concentration of soluble HLA class I in burn patientsMembrane and soluble forms of Fas (CD95) in peripheral blood lymphocytes and in serum from burns patientsSerum levels of different forms of soluble CD38 antigen in burned patients
P50
Q41468075-1189F922-3780-49A8-A9A8-397D962B9E07Q43038221-BDF22B07-653F-49A0-95EA-2F7CC1A43670Q43038680-B0A3B7ED-29B4-4E72-AC49-31C86B090EC0Q51548285-85743085-BE57-4D9A-BC53-8945AEBB8E09Q51720142-D9098C44-97D8-44C0-BB10-E5EF657BDAE7Q57692225-D5D7E47E-5A36-45AE-9AE2-721A99482C69Q60934529-31049D7C-22FD-4488-9D25-12C243C1E91FQ73075043-14C83C89-A34C-46E3-84E6-C636D1F2F86DQ74618607-7F8B9F46-9FB2-4C38-83DE-4A6CA040C97AQ80432102-98EF52CA-5BF2-46BA-BA38-9E134812C6CD
P50
description
researcher
@en
name
V V Novikov
@en
V V Novikov
@nl
type
label
V V Novikov
@en
V V Novikov
@nl
prefLabel
V V Novikov
@en
V V Novikov
@nl
P106
P108
P31
P496
0000-0002-2449-7213